Skip to content

A pilot study on the improvement of lower limb muscle hardness in patients with knee Osteoarthritis by Fu’s subcutaneous needling

A pilot study on the improvement of lower limb muscle hardness in patients with knee Osteoarthritis by Fu’s subcutaneous needling

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300073615
Enrollment
Unknown
Registered
2023-07-17
Start date
2023-07-17
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

koa

Interventions

Fu’s subcutaneous needling group :Fu’s subcutaneous needling
electroacupuncture group:electroacupuncture

Sponsors

Shandong Provincial Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Comply with the diagnostic criteria for knee osteoarthritis in the Guidelines for the Diagnosis and Treatment of Osteoarthritis (2007 edition) formulated by the American Rheumatic Association and the Orthopedic Branch of the Chinese Medical Association in 1995; Age: 45 to 75 years old, regardless of gender; (3) Two weeks before enrollment, the average NRS score of knee joint pain was > 3 points; (4) Disease grading, KOA imaging grading (Kellgren Lawrence, KL) ?-? levels; (5) No pain relieving drugs or acupuncture and moxibustion treatment in recent 2 weeks; Agree to participate in this study and sign an informed consent form. Only those who meet the above 6 criteria can be included in the study.

Exclusion criteria

Exclusion criteria: (1) History of knee surgery or are waiting for knee surgery (such as knee Joint replacement or knee Arthroscopy surgery); ? Knee joint pain caused by other diseases (such as severe joint effusion, malignant tumors, autoimmune diseases, trauma, and infections). (3) Individuals with obvious knee joint deformities such as eversion; (4) Individuals with a history of vascular and nerve injury in the affected limb; (5) Those with severe diseases such as cardiovascular, cerebrovascular, liver, kidney, and hematopoietic systems; (6) History of intrasegmental injection in the target joint in the past 6 months (7) Pregnant and lactating women patients;

Design outcomes

Primary

MeasureTime frame
average pain NRS scores;Young's modulus of Quadriceps;

Secondary

MeasureTime frame
WOMAC function subscale scores;SF-12 Quality of Life Survey Scale;

Countries

China

Contacts

Public ContactLi Hu

Shandong Provincial Third Hospital, Shandong University

378272967@qq.com+86 531 8165 6294

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026